UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 6, 2023

Accession Number:	0001193125-23-030326
Submission Type:	POS AM
CIK: 0001549595 Company Name: Nurix Therapeutics, Inc. File Number: 333-258448